New York A01287 ensures continuous coverage for single source drugs in prescription insurance policies until medically unnecessary.

New York A01287 amends the insurance law to mandate that every insurance policy providing coverage for prescription drugs must ensure continuous coverage of a single source drug, defined as a brandname drug without a generic equivalent, as part of a prescribed therapy until it is no longer medically necessary. This applies to both individual and group policies, and allows covered persons to maintain coverage while their grievance or appeal regarding a formulary change is being decided. The changes apply to policies and contracts issued, renewed, or amended after the act's effective date.

New York A01287 ensures continuous coverage for single source drugs in prescription insurance policies until medically unnecessary.

New York A01287 amends the insurance law to mandate that every insurance policy providing coverage for prescription drugs must ensure continuous coverage of a single source drug, defined as a brandname drug without a generic equivalent, as part of a prescribed therapy until it is no longer medically necessary. This applies to both individual and group policies, and allows covered persons to maintain coverage while their grievance or appeal regarding a formulary change is being decided. The changes apply to policies and contracts issued, renewed, or amended after the act's effective date.